Full name
ENOVIS POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
46.90.Z - Non-specialized wholesale trade
47.19.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.99.Z - Retail trade
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,5 | 1,4 | 3,2 | 133,6 |
EBITDA | 5,2 | 7,6 | 10,3 | 34,6 |
Short time liabilities | 19 | 27,2 | 43,2 | 58,8 |
Equity capital | -0,7 | 0,5 | 2,9 | 503,7 |
Operating profit (EBIT) | 1 | 2,3 | 3,4 | 46,9 |
Assets | 43,5 | 52 | 70,8 | 36 |
Net profit (loss) | 0,6 | 1,1 | 2,4 | 111,4 |
Cash | 3 | 3 | 1 | -66,1 |
Net income from sale | 25,3 | 38,3 | 57,9 | 51,2 |
Liabilities and provisions for liabilities | 44,1 | 51,5 | 67,9 | 31,7 |
Working assets | 28 | 34,3 | 44 | 28,1 |
Depreciation | 4,2 | 5,4 | 6,9 | 29,3 |
% | % | % | p.p. | |
Profitability of capital | -85 | 238,3 | 83,4 | -154,9 |
Equity capital to total assets | -1,5 | 0,9 | 4 | 3,1 |
Gross profit margin | 2 | 3,5 | 5,5 | 2 |
EBITDA Margin | 20,6 | 20 | 17,8 | -2,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 274 | 259 | 272 | 13 |
Current financial liquidity indicator | 1.4616341590881348 | 1.2606258392333984 | 1.0160329341888428 | -0,3 |
Net dept to EBITDA | 5.002667427062988 | 3.454709768295288 | 3.6509134769439697 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane